UKBizDB.co.uk

FORTINGALL THERAPEUTICS INTERNATIONAL LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Fortingall Therapeutics International Limited. The company was founded 7 years ago and was given the registration number SC594337. The firm's registered office is in EDINBURGH. You can find them at 7 / 4 Meggetland View, , Edinburgh, . This company's SIC code is 21200 - Manufacture of pharmaceutical preparations.

Company Information

Name:FORTINGALL THERAPEUTICS INTERNATIONAL LIMITED
Company Number:SC594337
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:13 April 2018
End of financial year:30 April 2023
Jurisdiction:Scotland
Industry Codes:
  • 21200 - Manufacture of pharmaceutical preparations

Office Address & Contact

Registered Address:7 / 4 Meggetland View, Edinburgh, United Kingdom, EH14 1XT
Country Origin:UNITED KINGDOM
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
7 / 4, Meggetland View, Edinburgh, United Kingdom, EH14 1XT

Director13 April 2018Active
The Apex, 2 Sheriffs Orchard, Coventry, England, CV1 3PP

Corporate Secretary16 April 2018Active

People with Significant Control

Marc Turner
Notified on:13 April 2018
Status:Active
Date of birth:July 1959
Nationality:British
Country of residence:United Kingdom
Address:7 / 4, Meggetland View, Edinburgh, United Kingdom, EH14 1XT
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (5 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (7 months remaining)

Copyright © 2025. All rights reserved.